Cyanocobalamin intranasal - Fleming Pharmaceuticals
Alternative Names: CaloMistLatest Information Update: 02 Oct 2021
At a glance
- Originator Fleming Pharmaceuticals
- Class Corrinoids; Vitamin B12 analogues
- Mechanism of Action Vitamin B 12 replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Vitamin deficiency
Most Recent Events
- 01 Dec 2007 Launched for Vitamin deficiency in USA (Intranasal)